111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Analyze analyst forecasts for the company and compare them with competitors.
38.39B
Better than CX's estimated revenue of 17.01B.
6.05B
Better than CX's estimated ebitda of 2.47B.
5.53
Worse than CX's estimated eps of 12.47.
3.97B
Worse than CX's estimated net income of 18.33B.
3.91B
Better than CX's estimated ebit of 1.16B.
8.60B
Worse than CX's estimated sg&a expense of 3.20B.
Analyze DCF forecasts for the company and compare them with competitors.
42.85B
Better than CX's revenue of 993.22M.
8.68%
Better than CX's revenue growth rate of 7.41%.
6.75B
Better than CX's ebitda of 144.22M.
15.75%
Better than CX's ebitda margin of 14.52%.
4.37B
Better than CX's ebit of 67.75M.
10.19%
Better than CX's ebit margin of 6.82%.
2.38B
Worse than CX's depreciation of 76.47M.
10.13B
Better than CX's total cash of 48.28M.
23.64%
Better than CX's cash as percentage of revenue of 4.86%.
3.32B
Worse than CX's receivables of 112.18M.
7.75%
Better than CX's receivables as percentage of revenue of 11.29%.
5.06B
Worse than CX's inventories of 88.77M.
11.80%
Worse than CX's inventories as percentage of revenue of 8.94%.
3.53B
Worse than CX's accounts payable of 188.65M.
8.23%
Better than CX's payables as percentage of revenue of 18.99%.
-2.00B
Better than CX's capital expenditure of -61.16M.
-4.66%
Worse than CX's capex as percentage of revenue of -6.16%.
9.65%
Worse than CX's weighted average cost of capital (wacc) of 9.43%.
10.90%
Worse than CX's cost of equity of 9.69%.
4.40%
Better than CX's cost of debt of 7.04%.
1.38
Worse than CX's beta of 1.12.
729.20M
Better than CX's diluted shares outstanding of 1.47B.
13.52B
Worse than CX's total debt of 404.20M.
68.33B
Better than CX's total equity of 8.15B.
81.85B
Better than CX's total capital of 8.55B.
16.51%
Worse than CX's debt weighting of 4.73%.
83.49%
Worse than CX's equity weighting of 95.27%.
3.30B
Better than CX's ebiat of 40.95M.
3.29B
Better than CX's unlevered free cash flow of 55.41M.
2.00%
Equal to CX's long-term growth rate of 2.00%.
56.34B
Better than CX's terminal value of 942.19M.
50.72B
Better than CX's enterprise value of 837.22M.
6.94B
Worse than CX's net debt of 373.30M.
43.78B
Better than CX's equity value of 463.91M.
60.04
Better than CX's equity value per share of 0.32.
View analysts' price targets and recommendations, and compare them with competitors.
$114.00
Lower downside than CX's downside of 16.39%.
Buy
Better than CX's analyst recommendation of Hold.
